The United States stands at a peculiar and troubling inflection point in the history of mental healthcare. For decades, the prevailing narrative has been one of increasing awareness and access. Counseling has transcended clinical settings to become mainstream culture, referenced in podcasts, hit books, and blockbuster films. Professional athletes, celebrities, and politicians routinely publicize their struggles, effectively destigmatizing the concept of seeking help. Data confirms this cultural shift: by recent federal estimates, approximately one in eight U.S. adults now takes an antidepressant, and one in five has recently received some form of mental health care. This represents an increase of nearly 15 million people in treatment since 2002. Between 2019 and 2022 alone, the utilization of mental health services among adults with commercial insurance jumped by almost 40 percent.
Yet, despite this surge in engagement, the broader metric of population mental health is deteriorating. Trends are moving in the wrong direction. As of late 2022, only 31 percent of U.S. adults considered their mental health to be "excellent," a significant decline from the 43 percent reported two decades earlier. Suicide rates have risen by approximately 30 percent since 2000. Furthermore, nearly one-third of U.S. adults now report symptoms of depression or anxiety, a figure roughly three times higher than in 2019. About one in 25 adults suffers from a serious mental illness such as bipolar disorder or schizophrenia. The data presents a paradox: more people are seeking help, but the collective mental well-being of the nation is declining. This discrepancy suggests that simply expanding access to conventional treatments is insufficient to address the root causes of the current crisis.
The failure to treat mental health issues effectively is not merely a matter of supply and demand. It is a systemic failure involving diagnostic inaccuracies, reimbursement barriers, and a fundamental disconnect between the biological reality of mental illness and the current treatment models. While the cultural conversation about mental health has exploded, the actual outcomes for patients remain poor. A significant portion of the population with diagnosed conditions cannot access care, even when insured. A 2023 report by the actuarial firm Milliman, commissioned by the mental health advocacy group Inseparable, revealed that roughly two-thirds of Americans with a diagnosed mental health condition were unable to access treatment in 2021, despite having health insurance. Furthermore, among those who visited an emergency department or hospital during a mental health crisis, only one-third received follow-up care within a month of being discharged.
This report illuminates the depth of the access crisis. The barriers are multifaceted, including a severe workforce shortage, poor reimbursement rates for providers, and substandard enforcement of laws requiring insurance companies to cover mental health conditions. As Bill Smith, founder of Inseparable, noted, families have long shared "nightmare stories" of care being denied by insurance companies, but lacked the data to quantify the extent of the problem. The Milliman report confirms that access impediments remain a primary driver of treatment failure. However, the crisis runs deeper than insurance denials. Even when patients bypass access barriers and reach a provider, the treatment often fails to produce lasting results.
The current mental healthcare landscape is characterized by a "trial and error" approach that often leaves patients feeling like a "dartboard" upon which providers throw various therapeutic and pharmacological interventions to see what sticks. Joseph Mancuso, a 35-year-old music producer and content creator from Texas, exemplifies this frustrating reality. Diagnosed with depression and bipolar disorder over the years, he felt the diagnoses were never quite accurate until he was later diagnosed with complex post-traumatic stress disorder. This delay in accurate diagnosis led to numerous prescriptions, many of which were ineffective. Similarly, an antidepressant may be prescribed for what appears to be major depression, only to fail because the patient actually has bipolar disorder, a condition that often presents with depressive symptoms but requires a completely different pharmacological approach. This diagnostic uncertainty contributes significantly to the high rate of treatment failure.
The inefficacy of current treatments is further highlighted by research re-analyzing the data behind supposedly evidence-based therapies. While some methods, such as exposure therapy for phobias, show strong efficacy, many other standard interventions yield mixed results. The disconnect is stark: if the system were working as intended, the aggregate mental health of the population should be improving as access increases. Instead, the metrics are worsening. Dr. Thomas Insel, former director of the National Institute of Mental Health, points out that this negative trend is unique to mental health; in other areas of medicine like cancer, heart disease, and diabetes, survival rates and management have improved over time.
A critical, often overlooked dimension of this failure is the separation of mental health from physical health. Conventional mental health therapies, including talk therapy and psychotropics, attempt to address psychosocial and biological symptoms, but they often ignore the deep interplay between mental illness and metabolic health. Recent research increasingly suggests that the parallel rise in metabolic diseases (obesity, diabetes, non-alcoholic liver disease) and mental illness is not a coincidence. The U.S. mental health crisis is deeply intertwined with the metabolic crisis.
A more comprehensive biopsychosocial model is required to resolve this disconnect. The current paradigm often treats mental health as an isolated domain, separate from the body's physiological state. However, mental health providers need to work more closely with primary care providers and biomedical specialists to improve symptom understanding and treatment efficacy. Integrating metabolic assessments into mental health care could revolutionize outcomes. This would involve augmenting standard mental health assessments with routine medical testing for metabolic disorders, including insulin levels, blood glucose, liver function, and C-reactive protein.
The failure to integrate these domains means that millions of patients are receiving treatments that do not address the underlying biological causes of their distress. For example, a patient presenting with anxiety or depression might have undiagnosed insulin resistance or chronic inflammation, which standard psychiatric protocols often miss. By combining conventional mental health treatments with behavior interventions that improve metabolic function—such as nutrition, sleep optimization, healthy fat loss, and physical activity—clinicians can target the root causes rather than just the symptoms. Furthermore, education about and testing for established endocrine disruptors and environmental toxins linked to both obesity and mental illness could become a critical component of treatment planning.
The following table outlines the critical gaps in the current U.S. mental health treatment system, contrasting the ideal model with the current reality:
| Aspect | Current Reality | Ideal Integrated Model |
|---|---|---|
| Diagnostic Accuracy | High rate of misdiagnosis; "dartboard" approach to medication trials. | Precision diagnostics integrating metabolic and environmental factors. |
| Treatment Efficacy | Antidepressants and therapy often fail to produce sustained remission. | Personalized combinations of therapy, medication, and metabolic interventions. |
| Access Barriers | Two-thirds of diagnosed patients cannot access care; poor follow-up after ER visits. | Streamlined insurance coverage; robust post-discharge care coordination. |
| Provider Collaboration | Mental health and primary care operate in silos. | Close collaboration between psychiatrists, PCPs, and metabolic specialists. |
| Holistic Assessment | Focuses primarily on psychosocial symptoms. | Includes routine metabolic testing (glucose, CRP, insulin) and environmental toxin screening. |
| Population Outcomes | Declining self-rated mental health; rising suicide rates. | Stabilizing or improving population metrics through root-cause treatment. |
The data from the Milliman report underscores the structural failures. Nearly a quarter of people with insurance—covering Medicaid, commercial, and Medicare—had at least one mental health diagnosis in 2021. Yet, the majority of these individuals remain untreated. The barriers are not just financial; they are systemic. Poor reimbursement rates discourage providers from accepting new patients, creating a workforce shortage. This shortage, combined with aggressive insurance denials, leaves a vast majority of diagnosed individuals without support.
Meiram Bendat, a psychotherapist and attorney who founded PsychAppeal, notes that while the findings are not entirely surprising, the persistence of access impediments is striking. The report confirms that identifiable conditions often go untreated because patients cannot find providers. The lack of follow-up care is particularly alarming. When a patient is discharged from the hospital after a mental health crisis, the system fails to provide continuity of care for the vast majority, leaving them vulnerable to relapse. This lack of continuity contributes to the cyclical nature of mental health crises, where patients bounce in and out of emergency services without receiving the long-term support necessary for recovery.
The rise in mental health service utilization in the U.S. is partly driven by a decrease in stigma, as noted by Dr. Robert Trestman of the American Psychiatric Association. While more people are comfortable seeking care, the demand has skyrocketed in the wake of societal disruptions like the pandemic and the Great Recession. This increased demand has placed immense strain on an already taxed system, resulting in longer wait times, limited provider availability, and increased pressure on emergency services. The system is drowning in demand but failing to deliver the quality or quantity of care needed to reverse the negative trends in population health.
Beyond the access crisis, there is a fundamental flaw in how mental illness is conceptualized and treated. The prevailing model often treats symptoms in isolation. A patient with anxiety might receive an SSRI, but if that anxiety is driven by chronic inflammation or metabolic dysregulation, the medication alone is unlikely to be curative. This explains why, despite the high prescription rates of antidepressants, the overall mental health of the population continues to decline. The "missing piece" of the crisis is the failure to address the non-psychosocial causes of mental illness.
To move forward, the U.S. mental healthcare system must undergo a fundamental transformation. This involves shifting from a symptom-focused model to a root-cause model. Mental health providers must integrate metabolic health assessments into their standard of care. This includes routine testing for insulin levels, blood glucose, liver function, and inflammatory markers like C-reactive protein. By identifying and treating these physiological contributors, clinicians can offer more effective, personalized treatment plans.
Furthermore, the system must address the environmental determinants of mental health. Exposure to endocrine disruptors and toxins is increasingly linked to both metabolic disease and mental illness. Screening for these exposures and educating patients on reducing exposure should become a standard part of mental health treatment. This holistic approach acknowledges that the mind and body are inextricably linked, and that treating the mind requires treating the body.
The personal narrative of Joseph Mancuso highlights the human cost of these systemic failures. Feeling like a "dartboard" where treatments are tested until one works is a common experience for patients navigating the current system. This "trial and error" approach is inefficient and often traumatic for the patient. A more rigorous, data-driven approach that considers metabolic and environmental factors would reduce the time to accurate diagnosis and effective treatment.
The disconnect between rising treatment utilization and declining mental health outcomes is a signal that the current paradigm is broken. The data is unambiguous: the U.S. has reached "peak therapy" in terms of cultural awareness and service utilization, but the underlying health of the population is deteriorating. Suicide rates have climbed, and self-reported mental health has plummeted. This suggests that the current tools—medication and talk therapy—are insufficient when applied in a vacuum, without addressing the broader biological and environmental context.
The path to improving mental health in the U.S. requires a paradigm shift. It demands a move away from the siloed approach where mental health is treated separately from physical health. The integration of metabolic testing, environmental screening, and lifestyle interventions into mental health care represents the "missing piece" that could turn the tide. Without this integration, the cycle of access barriers and ineffective treatments will continue, leaving millions of Americans without the support they desperately need.
The Milliman report provides the hard data on the access crisis, while the broader scientific consensus points to the need for a biopsychosocial approach. The convergence of these insights reveals that the failure to treat mental health issues is not just a shortage of therapists or medications, but a failure to understand the complex, multifactorial nature of mental illness. Addressing this requires a system-wide change in how mental health is conceptualized, assessed, and treated. The future of U.S. mental health depends on moving beyond the current limitations of conventional therapies and embracing a model that fully integrates mental and metabolic health.
Conclusion
The United States is currently experiencing a profound paradox in mental health care: while access to services is increasing and cultural awareness is at an all-time high, the overall mental health of the population is deteriorating. This divergence indicates a systemic failure in the current treatment paradigm. The Milliman report highlights the severe access barriers, revealing that the majority of diagnosed individuals remain untreated due to insurance denials and provider shortages. However, the crisis extends beyond mere access; it lies in the efficacy of the treatments provided. The "trial and error" approach to medication and the frequent misdiagnosis of conditions like bipolar disorder as depression contribute to poor outcomes.
Critically, the current mental health model fails to account for the deep biological and environmental roots of mental illness. The parallel rise in metabolic diseases suggests that mental health is inextricably linked to physical health, a connection that standard psychiatric protocols often ignore. To reverse the worsening trends in suicide rates and self-rated mental health, the U.S. healthcare system must adopt a comprehensive biopsychosocial model. This involves integrating metabolic testing, environmental screening, and lifestyle interventions into standard mental health care. Only by addressing the root causes—metabolic dysfunction, environmental toxins, and physiological inflammation—can the system hope to provide effective, lasting relief. The current trajectory is unsustainable, and a fundamental shift in how mental health is conceptualized and treated is essential to address the national crisis.
Sources
- Most Americans with Mental Health Needs Don't Get Treatment, Report Finds
- Therapy, Mental Health Worse in US
- The Missing Piece of the US Mental Health Crisis
- Impact of COVID-19 Pandemic on Mental Health in the General Population: A Systematic Review
- JAMA Health Forum Study on Mental Health Service Utilization